Literature DB >> 18173070

[Brucellosis: retrospective evaluation of the clinical, laboratory and epidemiological features of 151 cases].

Y Ziya Demiroğlu1, Tuba Turunç, Hikmet Alişkan, Sule Colakoğlu, Hande Arslan.   

Abstract

The aim of this study was to retrospectively evaluate the clinical and laboratory characteristics, complications and treatment oucomes of 151 brucellosis cases (age range: 15-79 years; 89 female), who were followed in our clinic between the period of January 2003-July 2005. Of them, 66.2% were diagnosed as acute, 23.8% as subacute and 9.9% as chronic brucellosis. Risk factors were detected as consumption of unpasteurized milk and diary products (80%), stock-breeding (14%) and risky profession such as veterinary, laboratory technician and butcher (3.3%). Most common complaints were arthralgia (87.4%), malaise (86%), fever (79.5%), sweating (78%), and waist pain (71%). In view of laboratory findings, increased erytrocyte sedimentation rate was detected in 61.6%, C-reactive protein positivity in 60%, lymphomonocytosis in 44.4% and anemia in 51.7% of them. Blood cultures were performed from 125 of the patients, and 64 (51.2%) of them yielded Brucella spp. The other specimens in which bacterial growth were detected in one of each, were bone marrow, sternoclavicular joint, psoas abscess, urine and pleural fluid. Standard tube agglutination (STA) test was found negative in 1.3% of patients who were culture positive, while it was positive at 1/160 titer in 20.5%, at 1/320 in 14%, at 1/640 in 14.6% and > or = 1/1280 in 49.7 percent. The most common complication was found as musculo-skeletal system involvement (30 spondylodiscitis, 15 sacroileitis, five peripheric arthritis, one tendinitis) with a rate of 33.7 percent. Other complications were nervous system involvement in 6% (two acute and seven chronic meningitis), genitourinary involvement in 5.3% (five epididymo-orchitis, two prostatitis, one with Brucella positive urine culture), peritonitis in 0.6% and skin involvement in 0.6 percent. Seven different therapy protocols were applied to the patients according to complications and case specialty, however doxycycline+rifampicin combination during six weeks was the most preferred one. Relapse and unresponsiveness to the therapy were detected in 8% and 2% of the cases, respectively. Gastrointestinal intolerance was found as the most common side effect. In conclusion, since brucellosis which is endemic in Turkey, displays diagnostic difficulties due to the various clinical presentations and leads to labor loss due to serious complications, it should be considered in the differential diagnosis of numerous diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18173070

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  8 in total

1.  Negative serology: could exclude the diagnosis of brucellosis?

Authors:  Aygul Dogan Çelik; Zerrin Yulugkural; Cumhur Kilincer; Mustafa Kemal Hamamcioglu; Figen Kuloglu; Filiz Akata
Journal:  Rheumatol Int       Date:  2010-04-09       Impact factor: 2.631

2.  Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.

Authors:  Mile Bosilkovski; Ljiljana Krteva; Marija Dimzova; Ivan Vidinic; Zaklina Sopova; Katerina Spasovska
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

3.  Chest wall involvement as a manifestation of brucellosis.

Authors:  K Rahmdel; R Golsha; E Golshah; R Rezaie Shirazi; N Sadre Momtaz
Journal:  J Glob Infect Dis       Date:  2011-01

4.  Epididymoorchitis as the first finding in patients with brucellosis.

Authors:  Ayhan Karaköse; Mehmet Bilgehan Yuksel; Ozgü Aydoğdu; Aziz Ahmad Hamidi
Journal:  Adv Urol       Date:  2013-12-26

5.  Epidemiological and Clinical Features of People with Malta Fever in Iran: A Systematic Review and Meta-Analysis.

Authors:  Mahmood Moosazadeh; Roja Nikaeen; Ghasem Abedi; Motahareh Kheradmand; Saeid Safiri
Journal:  Osong Public Health Res Perspect       Date:  2016-05-04

6.  The clinical features of 590 patients with brucellosis in Xinjiang, China with the emphasis on the treatment of complications.

Authors:  Bin Jia; Fengbo Zhang; Ying Lu; Wenbao Zhang; Jun Li; Yuexin Zhang; Jianbing Ding
Journal:  PLoS Negl Trop Dis       Date:  2017-05-01

7.  Comparison of inflammatory markers between brucella and non-brucella epididymo-orchitis.

Authors:  Ali Cift; Mehmet Ozgur Yucel
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

8.  Demographic, Laboratory, and Clinical Comparison of Pediatric Brucella Cases With and Without Liver Involvement.

Authors:  Mehmet Agin; Yusuf Kayar
Journal:  Cureus       Date:  2020-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.